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Book Review: Thieves of Virtue: When Bioethics Stole
Medicine
Bioethics emerged in the 1960s from a conviction that physicians and researchers needed the
guidance of philosophers in handling the issues raised by technological advances in medicine.
In this book, Tom Koch argues that bioethics has failed to deliver on its promises and has
promoted a view of medicine as a commodity whose delivery is predicated not on care but on
economic efficiency. Edward Larkin thinks Koch provides an interesting history of the field, but
he unnecessarily blames bioethicists for recent developments in health care and medicine.
Thieves of Virtue: When Bioethics Stole Medicine. Tom Koch. MIT Press. September
2012.
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Tom Koch’s book, Thieves of  Virtue: When Bioethics Stole Medicine
immediately demands a f ew questions f rom the prospective reader. First,
why choose to say “when bioethics stole medicine?”. Why not “how
bioethics stole medicine,” or “why“? Second, what exactly does it mean to
“steal” medicine? Koch quickly addresses this choice and posits that by
imposing an artif icial narrative of  scarcity, 20th century bioethics has
replaced the age-old ethics of  medicine embodied in the Hippocratic Oath
(f irst, do no harm) with its own inadequate moral codes.
Wait…artif icial narrative of  scarcity? The United States currently spends
about 18% of  GDP on health care. Other countries, like the UK, spend a
more manageable 10% of  GDP on health care, but costs are rapidly rising
with no signs of  abatement. Most economists consider this level of
spending to be wastef ul and inef f icient. A minority of  economists have
argued cogently and compellingly that 18% of  GDP is not necessarily inef f icient, and that the US
gets good value f or its spending. Almost none, however, would claim that there is room to
increase spending, and that scarcity is artif icial.
Koch claims that bioethics has persuaded people that resources are scarce, and theref ore
should be apportioned by valid ethical criteria (devised, of  course, by bioethicists themselves), and that in
doing so, they are advancing a neoliberal, individualistic agenda. In my experience, I have f ound this couldn’t
be f arther f rom the truth. Bioethics usually advances the exact opposite philosophy. Bioethicists object to
market allocations of  medical resources, which are apportioned based on ability and willingness to pay.
Bioethicists also tend to advocate alternative distributions, like giving treatments f irst to the youngest in a
group, or to those that will f are best f rom the treatment, or to those who add the most ‘utility’ to society.
Of  course there is talk of  scarcity, but if  Koch’s issue with scarcity is better placed with economists than
bioethicists, since scarcity has been one of  the central tenets of  economics since the days of  Adam Smith.
Koch also bemoans the loss of  paternalism in medicine – the ‘good old days’ when patients listened to
doctors. That paternalism in medicine has declined is uncontroversial. However, in praxis, doctors still
dictate most treatment decisions. Whether patients actually are more participatory than they have been at
the past, or simply f ashion themselves more participatory, is an interesting and unanswered question. But
is the loss of  paternalism the f ault of  bioethics as Koch suggests? Maybe this is best answered by asking
another question — why was medicine paternalistic in the f irst place? We don’t necessarily trust investment
managers with our money, car dealers with our automotive interests, or real estate agents with the task of
f inding the best house at the best price. Why then do we trust doctors?
About 50 years ago, the Nobel prize-winning economist Kenneth Arrow attempted to answer this question
in his f amous article, “Uncertainty and the Welf are Economics of  Medical Care”. Arrow asserted that
because it is hard to verif y whether doctors make good decisions, our culture has created an ethic of  trust
and duty. If  a stock broker consistently achieves low return on your money, you might end of  f iring this
person. If  a surgeon f ails your knee surgery, f iring him or her isn’t likely to yield an optimal result as your
knee is already injured. Instead, we put in place licensure restrictions and enter into a trust relationship with
physicians. Koch claims that bioethics changed this through its sustained attack on physicians as arrogant
and self - interested. But in seeking to exonerate physicians, Koch seems to portray bioethicists the
arrogant and self - interested ones. If  there’s any lesson to be taken f rom the entire situation, it is that
nuance is needed in categorising entire classes of  people, whether they be physicians or bioethicists. Koch
unf ortunately does not provide that.
Are there other explanations f or why the physician is no longer the f ault less, noble f igure he or she once
was? A more benign explanation is that access to inf ormation has improved signif icantly – through
advances like the internet, and also consumer ratings – and this allow us to judge doctors based on
perf ormance, and theref ore we don’t need to trust them as much as we once did. Fif ty years ago, when
someone wanted a knee surgery, they were likely to rely on word of  mouth and/or hospital reputation.
These days, health consumers are beginning to use actual data to make these decisions. As the data
becomes more user- f riendly, these trends might increase, and our inherent trust in doctors will continue to
decline apace. We might brief ly mourn the degeneration of  the cultural pact between doctors and patients,
but it might actually be a posit ive development. For all the good that trust entails, it can also seriously
decrease competit ion. If  the medical system responds to this new normal by improving quality (as economic
theory would suggest), this trade-of f   may then prove more valuable than the loss of  trust.
In the end, Koch provides an interesting history of  bioethics, but his overall argument unnecessarily blames
bioethicists f or recent developments in health care and medicine. While bioethicists may have played some
role in emphasising scarcity rather than individual patient care in medicine, it was certainly not solely their
doing. Indeed, changing economic realit ies (health care costs) and a more sophisticated understanding of
which procedures work and which do not, have spurred many to consider the health care system as a whole
rather than individual patient-doctor interactions. And while “economic ef f iciency” might seem a cold and
antiseptic phrase when applied to health care, insof ar as it strives to maximize outcomes at minimal costs, I
would argue that it is something to be lauded rather than deplored.
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